Johnson & Johnson (JNJ) revenue

Revenue · fiscal 2025
$94.19B

Johnson & Johnson (JNJ) reported revenue of $94.19B in fiscal 2025 (the year ended December 31, 2025). That is 6.0% higher than the $88.82B of fiscal 2024. Figures as of 18 Nov 2026, 09:55 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Revenue, fiscal 2025
$94.19B
Change on fiscal 2024
+6.0%
Highest on record
$94.19Bfiscal 2025
Lowest on record
$61.10Bfiscal 2007
Fiscal years on record
192007–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Johnson & Johnson revenue, in more detail

Across the 19 fiscal years on record (2007–2025), the highest was $94.19B in fiscal 2025 and the lowest $61.10B in fiscal 2007.

History · 19 fiscal years

Revenue by fiscal year

Johnson & Johnson revenue, year by year

Johnson & Johnson (JNJ) revenue by fiscal year
Fiscal yearRevenueChangeYear ended
2025$94.19B 6.0% up
2024$88.82B 4.3% up
2023$85.16B 6.5% up
2022$79.99B—
2022$78.74B 4.7% down
2021$82.58B—
2019$82.06B 0.6% up
2018$81.58B 6.7% up
2017$76.45B—
2017$71.89B 2.6% up
2016$70.07B—
2014$74.33B 4.2% up
2013$71.31B 6.1% up
2012$67.22B—
2012$65.03B 5.6% up
2011$61.59B 0.5% down
2010$61.90B—
2008$63.75B 4.3% up
2007$61.10B—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement.

How to read it

Steady growth in revenue is the raw material for everything else; a fall means the company is selling less or charging less.

Revenue at health care companies of similar size

Revenue of Johnson & Johnson and comparable companies
CompanyRevenueFiscal year
Eli Lilly LLY$65.18B2025
Johnson & Johnson JNJ$94.19B2025
AbbVie ABBV$61.16B2025
Merck & Co MRK$65.01B2025
UnitedHealth Group UNH$447.57B2025
Novartis NVS$56.67B2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on JNJ

Johnson & Johnson, figure by figure

Johnson & Johnson (JNJ) overview: price, valuation and scorecardAll health care companies by market value

Johnson & Johnson revenue: questions and answers

What is Johnson & Johnson's revenue?

Johnson & Johnson (JNJ) reported revenue of $94.19B in fiscal 2025 (the year ended December 31, 2025). That is 6.0% higher than the $88.82B of fiscal 2024.

What are the highest and lowest revenue figures on record for Johnson & Johnson?

Across the 19 fiscal years on record (2007–2025), the highest was $94.19B in fiscal 2025 and the lowest $61.10B in fiscal 2007.

How is Johnson & Johnson's revenue calculated?

Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement. For Johnson & Johnson it is on record here for 19 fiscal years, 2007 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Johnson & Johnson (JNJ) revenue”, data as of 18 November 2026. https://funkfolio.com/stock/JNJ/revenue

Underlying data: the company's filings with the SEC and Yahoo Finance.